Umbro I, Tinti F, Fiacco F, Zavatto A, Piselli P, Di Natale V, Lai S, Vitarelli A, Corradini S Ginanni, Rossi M, Poli L, Berloco P B, Mitterhofer A P
Department of Clinical Medicine, Nephrology and Dialysis Unit, I Faculty of Medicine and Surgery, Sapienza University of Rome, Rome, Italy.
Transplant Proc. 2013 Sep;45(7):2676-9. doi: 10.1016/j.transproceed.2013.07.040.
Renal dysfunction in cirrhotic patients is primarily related to disturbances in circulatory function. In decompensated cirrhosis, ascites and water retention are associated with development of dilutional hyponatremia. The arterial resistive index (RI) is a measure of resistance to arterial flow within the renal vascular bed. Hyponatremia is an independent predictor of mortality in patients with ascites. The aim of this study was to evaluate intrarenal RI in end-stage liver disease (ESLD) patients awaiting liver transplantation (LT) and its association with renal and hepatic function as assessed by Model for End-Stage Liver Disease (MELD) and MELD-Na scores. We evaluated 40 cirrhotic patients (23 males, 17 females) awaiting LT from January 2009 to January 2012. Twenty-six of the 40 patients (65%) showed a renal RI ≥ 0.70, the normal value according to standard reported evaluations. Patients with RI ≥ 0.70 showed significantly higher MELD and MELD-Na scores as well as greater higher serum creatinine and lower serum sodium concentrations compared with subject displaying RI <0.70. The most relevant result of our study was the strong association between elevated renal RI in ESLD patients and advanced liver dysfunction, as demonstrated by MELD and MELD-Na scores, hyponatremia, ascites, and acute renal failure episodes. In conclusion, this study suggested that intrarenal RI assessment should be considered in the clinical and nephrologic monitoring of cirrhotic patients awaiting LT.
肝硬化患者的肾功能不全主要与循环功能紊乱有关。在失代偿期肝硬化中,腹水和水潴留与稀释性低钠血症的发生相关。动脉阻力指数(RI)是衡量肾血管床内动脉血流阻力的指标。低钠血症是腹水患者死亡率的独立预测因素。本研究的目的是评估等待肝移植(LT)的终末期肝病(ESLD)患者的肾内RI,及其与通过终末期肝病模型(MELD)和MELD-Na评分评估的肾功能和肝功能的关系。我们评估了2009年1月至2012年1月期间等待LT的40例肝硬化患者(23例男性,17例女性)。40例患者中有26例(65%)的肾RI≥0.70,这是根据标准报告评估的正常值。与肾RI<0.70的患者相比,肾RI≥0.70的患者的MELD和MELD-Na评分显著更高,血清肌酐更高,血清钠浓度更低。我们研究最相关的结果是,ESLD患者肾RI升高与严重肝功能不全之间存在密切关联,这通过MELD和MELD-Na评分、低钠血症、腹水和急性肾衰竭发作得以证明。总之,本研究表明,在对等待LT的肝硬化患者进行临床和肾脏监测时,应考虑评估肾内RI。